Comparison is not endorsement
For people researching ibogaine in the Bahamas, a clinic comparison should begin with limits. Public descriptions can be incomplete, policies can change, and a facility’s presentation cannot establish that a person is medically suitable for ibogaine or that risk has been adequately managed.
The broader Bahamas ibogaine overview can help place a comparison in context: legality, safety, travel, continuity of care, and individual health history are connected questions rather than separate checkboxes.
Ibogaine is associated with potentially serious risks, including cardiac concerns and medication interactions. The National Institute on Drug Abuse’s overview of ibogaine notes that research and safety questions remain important, especially outside a conventional clinical setting.